Cargando…

The Value of Adding Surveillance Cultures to Fluoroquinolone Prophylaxis in the Management of Multiresistant Gram Negative Bacterial Infections in Acute Myeloid Leukemia

Multidrug resistant Gram-Negative Bacterial Infections (MR-GNBI) are an increasing cause of mortality in acute myeloid leukemia (AML), compromising the success of antineoplastic therapy. We prospectively explored a novel strategy, including mandatory fluoroquinolone prophylaxis, weekly surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castañón, Christelle, Fernández Moreno, Ahinoa, Fernández Verdugo, Ana María, Fernández, Javier, Martínez Ortega, Carmen, Alaguero, Miguel, Nicolás, Concepción, Vilorio Marqués, Laura, Bernal, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912560/ https://www.ncbi.nlm.nih.gov/pubmed/31731650 http://dx.doi.org/10.3390/jcm8111985

Ejemplares similares

P1572: IMPACT OF GUT COLONIZATION BY GRAM NEGATIVE MULTIRESISTANT BACTERIA IN PATIENTS WITH ACUTE LEUKEMIA UNDERGOING INTENSIVE ANTINEOPLASTIC TREATMENT
por: Castañon Fernandez, C., et al.
Publicado: (2022)

Colistin in the treatment of infections from multiresistant Gram (-) bacilli
por: Markou, N, et al.
Publicado: (2002)

Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria
por: Fuzi, Miklos
Publicado: (2016)

Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania
por: Mshana, Stephen E, et al.
Publicado: (2009)

Transferable resistance in multiresistant Gram-negative bacteria isolated from hemocultures in Slovakia
por: Kulkova, N, et al.
Publicado: (2015)

Isolation of Highly Active Monoclonal Antibodies against Multiresistant Gram-Positive Bacteria
por: Rossmann, Friederike S., et al.
Publicado: (2015)

Mycoplasma bovis in Spanish Cattle Herds: Two Groups of Multiresistant Isolates Predominate, with One Remaining Susceptible to Fluoroquinolones
por: García-Galán, Ana, et al.
Publicado: (2020)

1087. Fluoroquinolone Prophylaxis vs. No Bacterial Prophylaxis in Hospitalized Neutropenic Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia
por: Buchanan, Carley, et al.
Publicado: (2019)

Colonization and infection by potential Gram-negative multiresistant microorganism in a medical–surgical ICU
por: Ramos, L Lorente, et al.
Publicado: (2008)

1545. Gram-Negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
por: Herrera, Fabián, et al.
Publicado: (2018)

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)

In Vitro Synergism of Silver Nanoparticles with Antibiotics as an Alternative Treatment in Multiresistant Uropathogens
por: Lopez-Carrizales, Montserrat, et al.
Publicado: (2018)

Pressure ulcer as a reservoir of multiresistant Gram-negative bacilli: risk factors for colonization and development of bacteremia
por: Braga, Iolanda A., et al.
Publicado: (2016)

Successful treatment of multiresistant Achromobacter xylosoxidans bacteremia in a child with acute myeloid leukemia
por: Tugcu, Deniz, et al.
Publicado: (2015)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistance
por: Nair, Ashwin, et al.
Publicado: (2023)

Dihydropyrimidinones Against Multiresistant Bacteria
por: Castro Jara, Marisa, et al.
Publicado: (2022)

Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone
por: Fernández, Tahia D., et al.
Publicado: (2016)

Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
por: Frantzeskaki, F, et al.
Publicado: (2006)

Xanthoepocin, a photolabile antibiotic of Penicillium ochrochloron CBS 123823 with high activity against multiresistant gram-positive bacteria
por: Vrabl, Pamela, et al.
Publicado: (2022)

Prevalence and Characterisation of Multiresistant Bacterial Strains Isolated in Pigs from the Island of Tenerife
por: Abreu, Rossana, et al.
Publicado: (2022)

Fluoroquinolones Protective against Cephalosporin Resistance in Gram-negative Nosocomial Pathogens
por: Schwaber, Mitchell J., et al.
Publicado: (2004)

Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli
por: Saini, Lalit, et al.
Publicado: (2013)

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD
por: Vilorio-Marqués, Laura, et al.
Publicado: (2022)

Multiresistant bacteria in icu: in the right path
por: Moreno, O, et al.
Publicado: (2015)

Multiresistant Tuberculosis and Its Paradoxical Manifestations
por: Soto-Hernández, José Luis
Publicado: (2016)

Multitarget Approaches against Multiresistant Superbugs
por: Gray, Declan Alan, et al.
Publicado: (2020)

Informing future research for carriage of multiresistant Gram-negative bacteria: problems with recruiting to an English stool sample community prevalence study
por: Lecky, Donna M, et al.
Publicado: (2017)

Targeting Multiresistant Gram-Positive Bacteria by Ruthenium, Osmium, Iridium and Rhodium Half-Sandwich Type Complexes With Bidentate Monosaccharide Ligands
por: Balázs, Bence, et al.
Publicado: (2022)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

Improvement of Gram-negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience
por: Lee, Rachael A, et al.
Publicado: (2017)

Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases
por: Richter, Sara N., et al.
Publicado: (2007)

Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population
por: Kockerols, Camille C.B., et al.
Publicado: (2022)

Risk factors for colonization and infection by multiresistant bacteria
por: Carvalho Brugger, S, et al.
Publicado: (2015)

Reply: Multiresistant Tuberculosis and Its Paradoxical Manifestations
por: Choi, Hee Jung
Publicado: (2016)

The Basis for Natural Multiresistance to Phage in Pseudomonas aeruginosa
por: Pourcel, Christine, et al.
Publicado: (2020)

N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
por: Laws, Mark, et al.
Publicado: (2020)

647. Adoption of the updated fluoroquinolones breakpoints for Gram negative bacteria in clinical microbiology laboratories
por: Sfeir, Maroun M
Publicado: (2020)

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
por: Chong, Yong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c6316db9bjq07m23pfff383km9